Full Text Available
Note: Clicking the button above will open the full text document at the original institutional repository in a new window.
| Published in: | OncoTargets and Therapy |
|---|---|
| Format: | Online Article RSS Article |
| Published: |
2026
|
| Subjects: | |
| Tags: |
No Tags, Be the first to tag this record!
|
| _version_ | 1870297336326914048 |
|---|---|
| collection | WordPress RSS FRELIP Feed Integration |
| container_title | OncoTargets and Therapy |
| description | |
| discipline_display | Oncology |
| discipline_facet | Oncology |
| format | Online Article RSS Article |
| genre | Journal Article |
| id | rss_article:101436 |
| institution | FRELIP |
| journal_source_facet | OncoTargets and Therapy |
| last_indexed | 2026-07-10T03:35:33.339Z |
| publishDate | 2026 |
| publishDateSort | 2026 |
| record_format | rss_article |
| spellingShingle | Sintilimab-Induced Sequential Multi-System Severe Immune-Related Adverse Events in an Elderly Patient with Esophageal Squamous Cell Carcinoma: A Case Report and Literature Review Oncology General Oncology |
| sub_discipline_display | General |
| sub_discipline_facet | General |
| subject_display | Oncology General Oncology |
| subject_facet | Oncology General Oncology |
| title | Sintilimab-Induced Sequential Multi-System Severe Immune-Related Adverse Events in an Elderly Patient with Esophageal Squamous Cell Carcinoma: A Case Report and Literature Review |
| title_alt | Eventos adversos inmunorrelacionados graves multisistémicos secuenciales inducidos por Sintilimab en un paciente anciano con carcinoma de células escamosas de esófago: Reporte de caso y revisión de la literatura Événements indésirables immuno-induits multi-systémiques sévères séquentiels induits par le sintilimab chez un patient âgé atteint d'un carcinome épidermoïde de l'œsophage : rapport de cas et revue de la littérature Eventos adversos imunológicos graves multissistêmicos sequenciais induzidos por Sintilimabe em paciente idoso com carcinoma espinocelular de esôfago: Relato de caso e revisão da literatura |
| title_auth | Sintilimab-Induced Sequential Multi-System Severe Immune-Related Adverse Events in an Elderly Patient with Esophageal Squamous Cell Carcinoma: A Case Report and Literature Review |
| title_es_txt | Eventos adversos inmunorrelacionados graves multisistémicos secuenciales inducidos por Sintilimab en un paciente anciano con carcinoma de células escamosas de esófago: Reporte de caso y revisión de la literatura |
| title_fr_txt | Événements indésirables immuno-induits multi-systémiques sévères séquentiels induits par le sintilimab chez un patient âgé atteint d'un carcinome épidermoïde de l'œsophage : rapport de cas et revue de la littérature |
| title_full | Sintilimab-Induced Sequential Multi-System Severe Immune-Related Adverse Events in an Elderly Patient with Esophageal Squamous Cell Carcinoma: A Case Report and Literature Review |
| title_fullStr | Sintilimab-Induced Sequential Multi-System Severe Immune-Related Adverse Events in an Elderly Patient with Esophageal Squamous Cell Carcinoma: A Case Report and Literature Review |
| title_full_unstemmed | Sintilimab-Induced Sequential Multi-System Severe Immune-Related Adverse Events in an Elderly Patient with Esophageal Squamous Cell Carcinoma: A Case Report and Literature Review |
| title_pt_txt | Eventos adversos imunológicos graves multissistêmicos sequenciais induzidos por Sintilimabe em paciente idoso com carcinoma espinocelular de esôfago: Relato de caso e revisão da literatura |
| title_short | Sintilimab-Induced Sequential Multi-System Severe Immune-Related Adverse Events in an Elderly Patient with Esophageal Squamous Cell Carcinoma: A Case Report and Literature Review |
| title_sort | sintilimab-induced sequential multi-system severe immune-related adverse events in an elderly patient with esophageal squamous cell carcinoma: a case report and literature review |
| topic | Oncology General Oncology |
| url | https://www.dovepress.com/sintilimab-induced-sequential-multi-system-severe-immune-related-adver-peer-reviewed-fulltext-article-OTT |